Libra Infusions (DHA:LIBRAINFU) Other Financing: BDT Mil (TTM As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT574.50
View Full Analysis

What is Libra Infusions Other Financing?

Libra Infusions DHA:LIBRAINFU +1.47% 20 Other Financing is BDT Mil as of Dec. 2020. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100.

Libra Infusions's Other Financing for the three months ended in Dec. 2020 was BDT Mil.

Libra Infusions's Other Financing for the trailing twelve months (TTM) ended in Dec. 2020 was BDT Mil.

Libra Infusions Other Financing Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Other Financing Chart

Libra Infusions Annual Data
Trend Jun19 Jun20 Jun21
Other Financing
-0.00 -0.00 -0.00

Libra Infusions Quarterly Data
Dec20
Other Financing -
DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of BDT Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Other Financing of BDT Mil as of Dec. 2020. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Libra Infusions and its competitors.
Is Libra Infusions' Other Financing too high?
Libra Infusions' current Other Financing is BDT Mil. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Other Financing compare to SECI and LENSF?
Libra Infusions' Other Financing of BDT Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Libra Infusions and its competitors. Libra Infusions's current Other Financing is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Other Financing of BDT Mil. The current Other Financing is BDT Mil. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Other Financing is BDT Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT574.50
Price